SCHEMBL28227779

SCHEMBL28227779

FC(F)(F)c1cccc(Cc2ncccc2Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
NR1H2 P55055 1/20 0.44
NR1H3 Q13133 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
IDO1 P14902 2/20 0.43
P2RX7 Q99572 3/20 0.43
HTR2C P28335 2/20 0.43
HTR2B P41595 2/20 0.43
NR3C2 P08235 1/20 0.42
HTR2A P28223 1/20 0.42
DAO P14920 1/20 0.42
ACP3 P15309 1/20 0.41
MAOB P27338 1/20 0.40
LTA4H P09960 1/20 0.40
KCNN4 O15554 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2749287 0.78 ALDH1A1 (0.55) CYP1A2CYP3A4CYP2C9P2RX7NR3C2
SCHEMBL6950574 0.77 PARP1 (0.41) TAAR1IDO1MAOBKCNN4KDM4E
SCHEMBL28061641 0.76 KMT2A (0.53) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL18187098 0.76 NR3C2 (0.50) TAAR1IDO1HTR2CHTR2BNR3C2
SCHEMBL30047599 0.76 NR3C2 (0.50) TAAR1IDO1HTR2CHTR2BNR3C2
SCHEMBL5528278 0.76 KDM4E (0.44) NR1H2NR1H3TAAR1P2RX7KDM4E
SCHEMBL11602877 0.75 TP53 (0.51) CYP1A2CYP3A4CYP2D6CYP2C19TAAR1
SCHEMBL3237564 0.75 TAAR1 (0.64) TAAR1IDO1HTR2CHTR2BHTR2A
SCHEMBL4550514 0.75 KCNA5 (0.49) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2128638 0.74 ALDH1A1 (0.50) TAAR1IDO1HTR2CHTR2BNR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108174603-A 1-heteroaryl-indoline-4-carboxamides as GPR52 modulators for the treatment or prevention of disorders related thereto 阿芮纳制药有限公司 2018-06-15 CN disclosed